You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Sodium fluoride; triclosan - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sodium fluoride; triclosan and what is the scope of patent protection?

Sodium fluoride; triclosan is the generic ingredient in one branded drug marketed by Colgate Palmolive and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for sodium fluoride; triclosan
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 3
DailyMed Link:sodium fluoride; triclosan at DailyMed
Recent Clinical Trials for sodium fluoride; triclosan

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Colgate PalmolivePhase 4
Universidade Estadual de MaringáPhase 3
University of GuarulhosPhase 3

See all sodium fluoride; triclosan clinical trials

US Patents and Regulatory Information for sodium fluoride; triclosan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Colgate Palmolive COLGATE TOTAL sodium fluoride; triclosan PASTE;DENTAL 020231-001 Jul 11, 1997 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for sodium fluoride; triclosan

Sodium fluoride; triclosan Market Analysis and Financial Projection

Last updated: February 15, 2026

What Are the Market Dynamics for Sodium Fluoride and Triclosan?

Sodium fluoride and triclosan are active ingredients used in oral care and antimicrobial products, respectively. Market drivers, competitive landscape, regulatory pressures, and supply chain factors shape their current and future trajectories.

Sodium Fluoride Market Overview

Demand Drivers:

  • Oral health awareness has significantly increased. Globally, sales of toothpaste containing sodium fluoride accounted for approximately $11 billion in 2022.
  • Fluoridation programs in various countries, including the U.S. and parts of Europe, sustain steady demand.
  • Rising prevalence of dental caries and demand for preventive dental care push the market.

Supply & Production:

  • Large producers include companies like PQ Corporation and Solvay.
  • Price fluctuations depend on raw material costs like fluorosilicic acid and industry capacity utilization.
  • Industries tend to maintain inventories to hedge against raw material volatility.

Market Segments & Applications:

  • Toothpaste accounts for roughly 80% of sodium fluoride usage.
  • Other applications include mouthwashes and topical gels.

Geographic Dynamics:

  • North America and Europe generate dominant market shares due to established fluoridation programs.
  • Asia-Pacific shows high growth potential amid expanding dental care awareness and urbanization.

Triclosan Market Overview

Demand Drivers:

  • Incorporated into antimicrobial soaps, mouthwashes, and personal care products.
  • Market growth driven by consumer demand for antibacterial products and healthcare sector adoption.

Regulatory and Market Challenges:

  • Triclosan's use in consumer products faces bans and restrictions due to health and environmental safety concerns.
  • U.S. Food and Drug Administration (FDA) issued a final rule in 2016 banning triclosan in over-the-counter (OTC) soaps because safety and efficacy data are insufficient.
  • European Union also revised regulations, leading to reduced usage.

Manufacturers & Competition:

  • Major players include BASF and Adama.
  • Shifts toward alternative antimicrobials like benzalkonium chloride and chlorhexidine.

Market Outlook:

  • Declining demand in consumer personal care products.
  • Sustained use in medical devices and certain industrial applications.

Regulatory Environment Impact

Sodium Fluoride:

  • Generally recognized as safe (GRAS) for use in dental products when following regulatory standards.
  • Some cities or countries have limited water fluoridation, affecting demand.

Triclosan:

  • Increasing restrictions restrict its use, impacting supply and sales volume.
  • Companies pivot toward safer alternatives amid regulatory pressures.

Financial Trajectory

Sodium Fluoride:

  • The market exhibits stable growth, with a compounded annual growth rate (CAGR) of approximately 3% projected from 2023-2028.
  • Revenue estimates for sodium fluoride manufacturers stand at around $1.4 billion globally in 2022; growth driven by emerging markets.

Triclosan:

  • Market size declined from a peak of $600 million in 2015 to an estimated $250 million in 2022.
  • CAGR reduced to near-zero or negative as bans increased.
  • Industry revenue is expected to continue shrinking unless new uses or markets emerge.

Key Market Players and Their Strategies

Company Focus Areas Strategic Moves
PQ Corporation Sodium fluoride supply, specialty chemicals Capacity expansion; R&D on alternative fluorides
BASF Antimicrobial ingredients, specialty chemicals Divestment from triclosan-based products; focus on chlorhexidine and alternatives
Colgate-Palmolive Oral care products incorporating sodium fluoride Drive innovation in formulations; expand emerging markets
3M Oral and personal care products Reduce reliance on triclosan; develop alternative antimicrobials

What Are the Regulatory and Competitive Risks?

Sodium Fluoride:

  • Slightly impacted by water fluoridation policies; regulatory changes can influence regional demand.
  • The shift toward natural or additive-free products may affect growth projections.

Triclosan:

  • Regulatory bans sharply reduce potential markets.
  • Manufacturers face litigation and public scrutiny over environmental and health concerns.

How Do These Market Dynamics Affect Investment and R&D?

  • Sodium fluoride markets attract steady investment focused on process efficiencies and expanding applications.
  • Triclosan’s decline pushes companies toward safer, more sustainable antimicrobial solutions, supporting R&D in alternative compounds.

What Is the Long-Term Perspective for These Compounds?

Compound Outlook
Sodium fluoride Continued demand in dental health, especially in emerging markets; moderate growth persists with potential for innovation.
Triclosan Market contraction, with focus on replacing it with less controversial antimicrobials; viability in niche industrial applications remains uncertain.

Key Takeaways

  • Sodium fluoride maintains a stable, growing market driven by dental health initiatives worldwide.
  • Triclosan faces declining demand due to legal and health concerns, leading to reduced industry revenues.
  • Regulatory policies heavily influence supply, demand, and research directions.
  • Innovation centers on alternative active ingredients that address safety concerns.
  • Companies rewriting strategies to align with evolving regulations and consumer preferences.

FAQs

1. Will demand for sodium fluoride decline due to health concerns?
No. The evidence supports its safety in dental products when used within regulatory limits. Demand remains stable, especially in regions with active fluoridation programs.

2. Can triclosan regain market share?
Unlikely in consumer markets due to ongoing bans. Its use persists only in specific industrial or medical applications.

3. What alternatives are companies pursuing to replace triclosan?
Benzalkonium chloride, chlorhexidine, and natural antimicrobial agents are increasingly adopted.

4. How do regulatory changes affect the global supply chain?
Stringent regulations restrict market entry, lead to supply reductions, and push R&D toward compliant ingredients.

5. What emerging markets could reshape the sodium fluoride landscape?
Asia-Pacific countries and Latin America present growth opportunities driven by rising oral care awareness and expanding healthcare infrastructure.

References

[1] MarketsandMarkets. "Sodium Fluoride Market by Application, Region - Global Forecast to 2028."
[2] U.S. Food and Drug Administration. "Final Rule on Triclosan."
[3] Grand View Research. "Antimicrobial Market Size and Trends."
[4] Euromonitor International. "Oral Care Market Analysis."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.